Benzinga | May 4, 2021 04:12PM EDT

Sangamo Therapeutics Q1 EPS $(0.32) Misses $(0.30) Estimate, Sales $26.28M Beat $23.98M Estimate

Sangamo Therapeutics (NASDAQ:SGMO) reported quarterly losses of $(0.32) per share which missed the analyst consensus estimate of $(0.30) by 6.67 percent. This is a 13.51 percent increase over losses of $(0.37) per share from the same period last year. The company reported quarterly sales of $26.28 million which beat the analyst consensus estimate of $23.98 million by 9.59 percent. This is a 100.98 percent increase over sales of $13.08 million the same period last year.